Keytruda Pembrolizumab 50 mg Injection is an anti-cancer drug that belongs to a category called Monoclonal antibodies. Monoclonal antibodies are a newer advancement in treatment of Cancer. These work by “targeted” cancer therapy.
Keytruda Pembrolizumab 50 mg Injection interferes with the proliferation and spreading of cancer cells in your body. It is used in treatment of advanced stages of skin cancer like Malignant Metastasis Melanoma. This drug is used for treatment of certain non-small cell lung cancer, spreading and recurrent head and neck cancers and Hodgkin’s lymphoma too.
Adverse effects and Allergies are commonly seen with Keytruda Pembrolizumab 50 mg Injection.If you experience signs of allergy like: Hives, rashes, shortness of breath, dizziness, lightheadedness and angioedema.
This list of all side effects might not be complete that may occur with the administration of this injection. Please seek medical advice from your healthcare provider about concerns and queries regarding side effects.
- You must always inform your doctor of pharmacist about your past and present drug allergies or other allergies before taking this medication.Drug allergies to both active ingredients and inactive agents are common.